Dominic Calleja

Dominic Calleja

Auto-generated profile, based on publicly available information

Dominic Calleja

Institute for Risk and Uncertainty, University of Liverpool, Liverpool, United Kingdom

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NGNicholas Gray
Nicholas Gray
DCDominic Calleja
Dominic Calleja
AWAlexander Wimbush
Alexander Wimbush
EMEnrique Miralles-Dolz
Enrique Miralles-Dolz
AGAnder Gray
Ander Gray
SFScott Ferson
Scott Ferson
Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus. The present analysis uses a modified SIR model to understand the implication and magnitude of misdiagnosis in the context of ending lockdown measures. The results indicate that increased testing capacity alone will not provide a solution to lockdown measures. The progression of the epidemic and peak infections is shown to depend heavily on test characteristics, test targeting, and prevalence of the infection. Antibody based immunity passports are rejected as a solution to ending lockdown, as they can put the population at risk if poorly targeted. Similarly, mass screening for active viral infection may only be beneficial if it can be sufficiently well targeted, otherwise reliance on this approach for protection of the population can again put them at risk. A well targeted active viral test combined with a slow release rate is a viable strategy for continuous suppression of the virus.

22 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NGNicholas Gray
Nicholas Gray
DCDominic Calleja
Dominic Calleja
AWAlexander Wimbush
Alexander Wimbush
EMEnrique Miralles-Dolz
Enrique Miralles-Dolz
AGAnder Gray
Ander Gray
SFScott Ferson
Scott Ferson
Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus. The present analysis uses a modified SIR model to understand the implication and magnitude of misdiagnosis in the context of ending lockdown measures. The results indicate that increased testing capacity alone will not provide a solution to lockdown measures. The progression of the epidemic and peak infections is shown to depend heavily on test characteristics, test targeting, and prevalence of the infection. Antibody based immunity passports are rejected as a solution to ending lockdown, as they can put the population at risk if poorly targeted. Similarly, mass screening for active viral infection may only be beneficial if it can be sufficiently well targeted, otherwise reliance on this approach for protection of the population can again put them at risk. A well targeted active viral test combined with a slow release rate is a viable strategy for continuous suppression of the virus.

23 August 2020 in Rheumatology
Verified
Journal Article
Closed access
BOBright Uchenna Oparaji
Bright Uchenna Oparaji
LCLouis Clearkin
Louis Clearkin
SFScott Ferson
Scott Ferson
MAMarco De Angelis
Marco De Angelis
MFMaria Ferrer-Fernandez
Maria Ferrer-Fernandez
EDElfrida Derrer-Merk
Elfrida Derrer-Merk